Stocks › ANIK
Anika Therapeutics, Inc.
ANIK·Nasdaq·
United States·USD
United States·USD$19.53
+0.41 (+2.14%)
Close · Oct 7, 2026 · Close Prices from Tiingo.com
ANIK
Anika Therapeutics, Inc. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
ANIKS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of ANIK by members of U.S. Congress · 12 on record
Whale Activity
Position changes in ANIK reported for 2026-06-30 by 10 tracked institutional filers
- Increased3
- New1
- Held1
- Decreased4
- Closed1
- No prior filing0
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 1.4M | $21.2M | decreased |
| VANGUARD CAPITAL MANAGEMENT LLC | 572.1K | $8.4M | decreased |
| RENAISSANCE TECHNOLOGIES LLC | 481.4K | $7.0M | decreased |
| TWO SIGMA INVESTMENTS, LP | 253.0K | $3.7M | increased |
| D. E. Shaw & Co., Inc. | 245.1K | $3.6M | increased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 76.8K | $1.1M | increased |
| DIKER MANAGEMENT LLC | 53.7K | $785K | held |
| Point72 Asset Management, L.P. | 22.5K | $329K | decreased |
| MILLENNIUM MANAGEMENT LLC | 14.4K | $211K | new |
| Citadel Advisors LLC | 0 | $0 | closed |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by ANIK insiders, by quarter · Form 4
Recent Insider Transactions
673 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Fischetti Gary PDirector · Director | Purchase | +1,000 | $20.32 | $20K | Aug 4, 2026 | Form 4 ↗ |
| Fischetti Gary PDirector · Director | Purchase | +1,000 | $20.75 | $21K | Aug 3, 2026 | Form 4 ↗ |
| Fischetti Gary PDirector | Grant / award | +10.4K | $0.00 | $0 | Jun 18, 2026 | Form 4 ↗ |
| HENNEMAN JOHN B IIIDirector | Grant / award | +10.4K | $0.00 | $0 | Jun 18, 2026 | Form 4 ↗ |
| Richard StephenDirector | Grant / award | +10.4K | $0.00 | $0 | Jun 18, 2026 | Form 4 ↗ |
| Capper Joseph HDirector | Grant / award | +10.4K | $0.00 | $0 | Jun 18, 2026 | Form 4 ↗ |
| CONLEY SHERYL LDirector | Grant / award | +10.4K | $0.00 | $0 | Jun 18, 2026 | Form 4 ↗ |
| Griffin Stephen D.President and CEO · Director | Tax withholding | −3,769 | $14.41 | $54K | Jun 3, 2026 | Form 4 ↗ |
| Griffin Stephen D.President and CEO · Director | Option exercise | +12.8K | — | — | Jun 3, 2026 | Form 4 ↗ |
| HENNEMAN JOHN B IIIDirector | Purchase | +5,000 | $14.66 | $73K | May 1, 2026 | Form 4 ↗ |
| Griffin Stephen D.President and CEO · Director | Purchase | +12.2K | $12.29 | $150K | Apr 30, 2026 | Form 4 ↗ |
| Colleran DavidEVP, General Counsel, Corp Sec | Tax withholding | −1,893 | $14.20 | $27K | Mar 15, 2026 | Form 4 ↗ |
| Colleran DavidEVP, General Counsel, Corp Sec | Option exercise | +6,449 | — | — | Mar 15, 2026 | Form 4 ↗ |
| Blanchard Cheryl RDirector | Tax withholding | −12.1K | $14.20 | $172K | Mar 15, 2026 | Form 4 ↗ |
| Blanchard Cheryl RDirector | Option exercise | +25.1K | — | — | Mar 15, 2026 | Form 4 ↗ |
| McLeod IanSVP, CAO & Treasurer | Tax withholding | −781 | $14.20 | $11K | Mar 15, 2026 | Form 4 ↗ |
| McLeod IanSVP, CAO & Treasurer | Option exercise | +2,658 | — | — | Mar 15, 2026 | Form 4 ↗ |
| Colleran DavidEVP, General Counsel, Corp Sec | Tax withholding | −4,168 | $14.20 | $59K | Mar 14, 2026 | Form 4 ↗ |
| Colleran DavidEVP, General Counsel, Corp Sec | Grant / award | +4,694 | $0.00 | $0 | Mar 14, 2026 | Form 4 ↗ |
| Colleran DavidEVP, General Counsel, Corp Sec | Option exercise | +9,388 | — | — | Mar 14, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding ANIK · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 397.8K | $5.8M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 311.3K | $4.6M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 123.7K | $2.4M | 0.01% | Jul 31, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 162.5K | $2.4M | 0.00% | Jun 30, 2026 |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 142.3K | $2.1M | 0.00% | Jun 30, 2026 |
| U.S. SMALL CAP VALUE PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 86.7K | $1.7M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF iShares Trust | 104.9K | $1.5M | 0.01% | Jun 30, 2026 |
| Avantis U.S. Small Cap Value ETF American Century ETF Trust | 102.0K | $1.5M | 0.01% | May 31, 2026 |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 61.1K | $1.2M | 0.01% | Jul 31, 2026 |
| Dimensional US Small Cap Value ETF Dimensional ETF Trust | 56.8K | $1.1M | 0.01% | Jul 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list ANIK's shares (CUSIP 035255108), each fund at its latest report since Mar 8, 2026, largest positions first. Bonds, options and short positions are left out.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming anika therapeutics as client
No lobbying filings found naming Anika Therapeutics, Inc. as the client.
- KING & SPALDING LLPANIKA THERAPEUTICS, INC. · 2020 Q3—
Filing ↗ - KING & SPALDING LLPANIKA THERAPEUTICS, INC. · 2020 Q2—
Filing ↗ - KING & SPALDING LLPANIKA THERAPEUTICS, INC. · 2020 Q1—
Filing ↗ - KING & SPALDING LLPANIKA THERAPEUTICS, INC. · 2019 Q4—
Filing ↗ - KING & SPALDING LLPANIKA THERAPEUTICS, INC. · 2019 Q3—
Filing ↗
Government Contracts
Federal awards to Anika Therapeutics, Inc. · USAspending
No federal contract awards found for Anika Therapeutics, Inc..
U.S. Patents
Recent USPTO applications naming Anika Therapeutics, Inc.
No USPTO patent applications found for Anika Therapeutics, Inc..
Annual Financials
From ANIK's 10-K filings · XBRL
No annual XBRL figures on record for ANIK. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in ANIK's price history.
Material Events (8-K)
Corporate events filed with the SEC
About Anika Therapeutics, Inc.
From SEC EDGAR company records
Industry (SIC 3841)Surgical & Medical Instruments & Apparatus
SectorHealthcare
HeadquartersBEDFORD, MA
IncorporatedDE
SEC CIK0000898437 ↗
Former namesANIKA THERAPEUTICS INC, ANIKA RESEARCH INC